Bupropion Hydrochloride Extended-Release Tablets in dosage form. Bupropion Hydrochloride, imported in 150 mg and 300 mg extended-release tablets, is a norepinephrine-dopamine reuptake inhibitor. It is indicated for the treatment of major depressive disorder (MDD) and for the prevention of seasonal major depressive episodes in patients with a diagnosis of seasonal affective disorder (SAD).
[1] Please importantly note that only the relevant portion of the related is displayed above. You may refer to the said customs ruling for the entire ruling explanation.
[1]. https://rulings.cbp.gov/ruling/N322628